The iShares Future Exponential Technologies ETF, trading under the ticker XT, is an exchange-traded fund designed to give investors broad exposure to companies at the forefront of technological innovation. An ETF is a basket of securities that trades on an exchange like a single stock, allowing investors to buy diversified exposure in one transaction. Rather than picking individual winners, XT tracks an index of businesses that create or adopt "exponential technologies" — innovations that can scale rapidly and transform entire industries.
XT is a passively managed fund, meaning its portfolio is built to mirror an underlying benchmark rather than reflect the discretionary decisions of an active manager. Its benchmark is the Morningstar Exponential Technologies Index, a subset of the broader Morningstar Global Markets Index. The fund generally invests at least 80% of its assets in the component securities of that index. The index identifies seven technology themes that Morningstar analysts view as having the potential to displace older technologies and generate meaningful economic benefits. The methodology evaluates both producers of these technologies and the companies that use them across sectors, giving the fund a global, cross-industry reach that extends well beyond a single technology niche. The fund was launched on March 19, 2015, and is issued by iShares, the ETF brand of asset-management giant BlackRock. It trades on the Nasdaq exchange and carries an expense ratio of 0.46%, which represents the annual fee charged to investors as a percentage of assets. To get a sense of comparable ideas, I ran a quick screen through Tickeron’s AI tools.
XT typically holds around 200 stocks, providing diversification across geographies and industries. Its sector exposure is heavily concentrated in information technology, which has historically represented roughly 45% of the portfolio, followed by health care at about 25%. Industrials, consumer discretionary, and communication services account for smaller but meaningful allocations. Because the underlying index spans the broader economy, the fund also holds a modest amount of financials, utilities, and materials. The fund is global but predominantly U.S.-focused, with U.S. stocks generally making up about 70% or more of holdings, alongside companies from developed markets such as the United Kingdom, Japan, and Germany, plus a smaller emerging-markets allocation. Top holdings have included large-cap names such as LLY (Eli Lilly), TXN (Texas Instruments), NVDA (NVIDIA), MSFT (Microsoft), and JNJ (Johnson & Johnson). Because holdings and weightings change over time, investors should review the current portfolio before making decisions.
XT attracts attention because it packages a broad innovation theme into a single, diversified instrument. Investors who want exposure to long-term trends such as artificial intelligence, robotics, cloud computing, and biotechnology — but who prefer not to concentrate risk in a handful of individual stocks — may find the fund's diversified structure appealing. Its rules-based approach also removes some of the subjectivity associated with actively managed thematic funds. The fund's financial profile reflects its growth orientation: the portfolio has historically carried a relatively high price-to-earnings ratio compared with broad-market benchmarks, consistent with holdings that command premium valuations. Its global mandate adds a layer of geographic diversification that purely U.S.-focused technology funds do not offer, while its blend of technology producers and users broadens the potential sources of return across the economy.
Investors should weigh several factors before considering XT. First, the fund is concentrated in technology and health care, so its performance can be sensitive to sector-specific developments such as regulatory changes, shifts in interest rates, or a rotation away from growth stocks. High-growth companies often carry elevated valuations, which can lead to greater volatility when sentiment changes. Second, as a passive fund, XT aims to track its index rather than outperform it, so investors may experience some degree of tracking error — the gap between the fund's return and its benchmark. Third, the expense ratio of 0.46%, while not extreme for a thematic fund, is higher than many broad-market index ETFs. Finally, the fund holds international and emerging-market securities, which introduces currency risk and geopolitical exposure alongside the standard market risk that all equity ETFs carry.
The iShares Future Exponential Technologies ETF stands out as a diversified, rules-based way to access global companies driving technological change across multiple sectors. By blending technology producers and users under a single benchmark, it offers investors a broad innovation theme without the concentration risk of individual stock selection. Its global reach, established track record, and transparent index methodology help explain why it remains a relevant reference point for investors interested in long-term technology-driven growth.
When reviewing funds like XT, I often turn to Tickeron's AI Screener to compare opportunities across sectors and spot patterns that fit my approach. It supports screening by technical indicators, fundamentals, volatility, trends, AI signals, and customizable filters, which helps streamline the process of identifying ideas that align with specific strategies.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
XT saw its Momentum Indicator move below the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned negative. In 60 of the 73 cases, the stock moved further down in the following days. The odds of a decline are at 82%.
The Moving Average Convergence Divergence Histogram (MACD) for XT turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
XT moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for XT crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for XT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where XT advanced for three days, in 254 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
XT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows